RASFFReference 2024.5121
Presencia de sustancia farmacológica (sildenafilo) en productos a base de miel //Presence of pharmacological substance (sildenafil) in honey-based products
Official information organised for easier consultation. The source publication remains authoritative.
RASFF
Identification and classification
- Reference
- 2024.5121
- Notification ID
- 695502
- Classification
- information notification for attention
- Risk decision
- potentially serious
- Product type
- food
- Notification basis
- official control on the market
- Status
- ec_validated
RASFF
Product
- Description
- Productos a base de miel///Honey-based products
- Distribution status
- Description
- information on distribution not (yet) available
- Notification ID
- 221
- Notification ID
- 24879230
- Category
- Description
- dietetic foods, food supplements and fortified foods
- Notification ID
- 18439
- Product descriptions
- Notification ID
- 24883583
- temperature
- Description
- ambient
- Notification ID
- 27368
- Notification ID
- 24883585
- temperature
- Description
- ambient
- Notification ID
- 27368
- Notification ID
- 24883586
- temperature
- Description
- ambient
- Notification ID
- 27368
- Notification ID
- 24883587
- temperature
- Description
- ambient
- Notification ID
- 27368
RASFF
Risk and analytical results
- hazardObserved
- Unofficial translation. Sildenafil is indicated to restore impaired erectile function by increasing penile blood flow by selective inhibition of phosphodiesterase 5 (PDE-5). PDE-5 inhibitors are contraindicated in patients with acute myocardial infarction, unstable angina, exertional angina, heart failure, uncontrolled arrhythmias, hypotension (blood pressure less than 90/50 mmHg), uncontrolled arterial hypertension, history of cerebral ischemic stroke (ischemic stroke), in patients with severe hepatic insufficiency and in persons with a history of non-arteritic anterior ischemic optic neuropathy or with hereditary degenerative retinal disorders such as retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases).
- Notification ID
- 104859
RASFF
Measures
- Action taken
- Description
- public warning - press release
- Notification ID
- 18838
- Notification ID
- 24936497
- takenBy
- Notification ID
- 5010
- isoCode
- ES
- organizationName
- Spain
RASFF
Origin, notification and distribution
- Origin
- United Arab Emirates
- Notifying country or territory
- Spain
- Published distribution
- information on distribution not (yet) available
RASFF
Published territorial roles
- Roles
- Role
- FOR_ATTENTION
- notificationId
- 695502
- Organisation
- code
- INFO
- countryNetworkOrganizationId
- 5680
- Description
- INFOSAN
- Notification ID
- 10340
- Roles
- Role
- NOTIFYING
- notificationId
- 695502
- Role
- NOTIFYING
- notificationId
- 695502
- Role
- FOR_FOLLOW_UP
- notificationId
- 695502
- Organisation
- code
- ES
- countryNetworkOrganizationId
- 5010
- Description
- Spain
- Notification ID
- 2
- Roles
- Role
- FOR_FOLLOW_UP
- notificationId
- 699316
- Role
- ORIGIN
- notificationId
- 695502
- Role
- OPERATOR
- notificationId
- 695502
- Organisation
- code
- AE
- countryNetworkOrganizationId
- 5229
- Description
- United Arab Emirates
- Notification ID
- 10224
RASFF
Follow-ups
- fupDate
- 09-07-2024 13:39:05
- fupId
- 697004
- fupNumber
- 1
- fupType
- Description
- measures taken
- Notification ID
- 27672
- networkOrganizationId
- 13501
- organizationCode
- ES
- organizationDescription
- FOOD AESAN
- fupDate
- 18-07-2024 12:00:14
- fupId
- 699316
- fupNumber
- 2
- fupType
- Description
- request
- Notification ID
- 27665
- networkOrganizationId
- 1
- organizationCode
- EU
- organizationDescription
- European Commission
RASFF
Public links
- 5010
- countryNetworkOrganizationId
- 5010
- Notification ID
- 35
- link
- http://aplicaciones.magrama.es/silum/web/novedades/novedades.jsp
- countryNetworkOrganizationId
- 5010
- Notification ID
- 36
Provenance and context
NagameAlert organises public RASFF data while preserving official values and keeping notification classification separate from the risk decision. The official record remains authoritative and should be checked for follow-ups and current status.